Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With

See also
Status	Clinical Trial	Phase
Completed	`NCT00370890` - A Trial of Adjuvant Chemotherapy in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy	Phase 3
Recruiting	`NCT04340024` - Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients
Completed	`NCT00697619` - To Evaluate the Efficacy of ZOMETA® in Treatment of Bone Metastases in Patients With Stage IV Nasopharyngeal Cancer	Phase 2
Completed	`NCT00078546` - EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC)	Phase 1
Recruiting	`NCT04453826` - Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma	Phase 3
Active, not recruiting	`NCT01074021` - Nimotuzumab in Combination With Chemoradiation for Nasopharyngeal Cancer	Phase 3
Active, not recruiting	`NCT03890185` - Docetaxal & Cisplatin vs LDFRT + Docetaxal & Cisplatin in Locally Advanced NPC	Phase 2
Not yet recruiting	`NCT04158414` - Applying PET/MR in Oncology - a Prospective Project	N/A
Completed	`NCT02608073` - A Study of Capecitabine (Xeloda) as First-Line Chemotherapy in Participants With Metastatic Nasopharyngeal Cancer	Phase 2
Completed	`NCT03656250` - Assessment of Treatment Response of Nasopharyngeal Cancer Using Simultaneous 18F-FDG-PET and MRI
Recruiting	`NCT02012699` - Integrated Cancer Repository for Cancer Research
Recruiting	`NCT04476641` - A Study of DC-CIK Immunotherapy in the Treatment of Solid Tumors	Phase 2
Terminated	`NCT03144661` - An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies	Phase 1
Recruiting	`NCT03003182` - A Study of Nasopharyngeal Carcinoma From Guangdong	N/A
Not yet recruiting	`NCT06349889` - Adebrelimab and Chemoradiotherapy in High-risk Locoregionally Advanced Nasopharyngeal Carcinoma	Phase 2
Not yet recruiting	`NCT05305131` - Phase II Randomised Trial of Induction Gemcitabine and Cisplatin Versus Gemcitabine, Cisplatin, Pembrolizumab and Bevacizumab (GPPB) in Nasopharyngeal Cancer	Phase 2
Completed	`NCT01800071` - A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma	Phase 1
Recruiting	`NCT00304694` - Whole-Body 18F-FDG PET in Induction Chemotherapeutic Response for Advanced NPC Patients	N/A
Recruiting	`NCT05638269` - A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China
Not yet recruiting	`NCT04875611` - Nivolumab in Nasopharyngeal Cancer With Progression During or After Platinum-based Treatment	Phase 2

NCT number	NCT01094405
Study type	Interventional
Source	Chinese University of Hong Kong
Contact
Status	Completed
Phase	Phase 2
Start date	March 31, 2010
Completion date	August 27, 2020

Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional Therapy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms